Multiple endocrine neoplasia type 1: Gene and syndromes;NEOPLASIE ENDOCRINIENNE MULTIPLE DE TYPE 1: DU SYNDROME AU GENE, DU GENE AUX SYNDROMES

Medecine Therapeutique

Volumn 4, Issue 2, 1998, Pages 147-156

  Calender, Alain ^a,b   Gaudray, Patrick ^a,b   Giraud, Sophie ^c   Murat, Arnaud ^d   Zhang, Chang X ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c CNRS   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; ENDOCRINE TUMOR; FAMILY; GENE; GENETIC PREDISPOSITION; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PRIMARY HYPERPARATHYROIDISM;

EID: 0031946392     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Wermer P. 1954. Genetic aspects of adenomatosis of endocrine glands. Am J Med 16 : 363-375.
2. Metz D.C., et al. 1994. Multiple Endocrine Neoplasia type 1 : clinical features and management. In : Bilezikian J.P., Levine M.A., Marcus R , eds. The Parathyroids. New York : Raven Press Ltd., 591-645.
3. Sheperd J.J. 1991. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized ? Arch Surg 126 : 935-952
4. Trump D., et al. 1996. Clinical studies of Multiple Endocrine Neoplasia type 1 (MEN 1). Q J Med 89 : 653-669.
5. Skogseid B., Oberg K. 1995. Experience with multiple endocrine neoplasia type 1 screening. J Int Med 238 : 255-261.
6. Skogseid B., et al. 1995. Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118 : 1077-1082.
7. Beckers A., et al. 1992. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN 1) : loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN 1 locus. J Clin Endoc Metab 75 : 564-570.
8. Gordon R.D. 1995. Primary hyperaldosteronism. J Endocrinol Invest 18 : 495-511.
9. Kato H., et al. 1997. Multiple Endocrine Neoplasia type 1 associated with spinal ependymoma. Jpn J Int Med 35 : 285-289.
10. Giraud S., et al. 1997. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab 82 : 3487-3492.
11. Darling T.N., Skarulis M.C., Steinberg S.M., Marx S.J., Spiegel A.M., Turner M.L. 1997. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133 . 853-857.
12. Chanson P., Cadiot G., Murat A., and the GENEM. 1997. Management of patients and subjects at risk for multiple endocrine neoplasia type 1 : MEN 1. Horm Res 47 : 211-220.
13. Thompson N.W. 1995. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 238 : 269-280.
14. Thompson N W. 1997. Multiple Endocrine Neoplasia type 1 : surgical therapy. Cancer Treat Res 89 : 407-419.
15. Goldstone A.P., Scott-Coombes D.M., Lynn J.A. 1996. Surgical management of gastrointestinal endocrine tumors. Baillieres Clin Gastroenterol 10 : 707-736.
16. Vedhuis J.D., Norton J.A., Wells S.A , Vinik A.I., Perry R.R. 1997. Surgical versus medical management of multiple endocrine neoplasia (MEN) type I. J Clin Endocrinol Metab 82 : 357-364
17. Mignon M., Cadiot G., Marmuse J.P., Lewin M.J. 1996. Is gastrinoma a medical disease ? Yale J Biol Med 69 : 289-300.
18. O'Brien T., O'Riordan D.S., Gharib H , Scheithauer B.W., Ebersold M.J., van Heerden J.A. 1996. Results of treatment of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1). Neurosurgery 39 : 273-278.
19. Burgess J.R., et al. 1996. Adrenal glands in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131 : 699-702.
20. Larsson C , Skogseid B., Oberg K., Nakamura Y., Nordenskjöld M. 1988. Multiple Endocrine Neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 : 85-87.
21. Byström C., et al. 1990. Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87 . 1968-1972.
22. Chandrasekharappa S.C., et al. 1997. Positionnai cloning of the gene for multiple endocrine neoplasia type 1. Science 276 : 404-407
23. The European Consortium on MEN 1. 1997. Identification of the multiple endocrine neoplasia type 1 (MEN 1) gene. Hum Mol Genet 6 : 1177-1183.
24. The European Consortium on MEN 1. 1996. Definition of the minimal multiple endocrine neoplasia type 1 (MEN 1) area based on a 5-Mb integrated map of proximal 11q13. Genomics 37 : 345-353.
25. Emmert-Buck M.R., et al. 1997. Localization of the multiple endocrine neoplasia type 1 (MEN 1) gene based on tumour loss of heterozygosity analysis. Cancer Res 57 : 1855-1858.
26. The European Consortium on MEN 1. 1997. Construction of a 1,2 Mb sequenceready contig of chromosome 11q13 encompassing the Multiple Endocrine Neoplasia type 1 (MEN 1) gene. Genomics 44 : 94-100.
27. Argawal S K., et al. 1997. Germline mutations of the MEN 1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6 : 1169-1175.
28. Giraud S., et al., in the framework of GENEM. Mutation analysis of the MEN 1 gene in French families with Multiple Endocrine Neoplasia type 1 (MEN 1) and related disorders. Am J Hum Genet (soumis).
29. The European Consortium on MEN 1. 1997. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN 1). Hum Genet 100 : 657-665.
30. Toliat M.R., Berger W., Roper H.H., Neuhaus P., Wiedenmann B. 1997. Mutations in the MEN 1 gene in sporadic neuroendocrine tumours of gastroenteropancreatic system Lancet 350 . 1223-1223.
31. Zhuang Z.P., et al. 1997. Somatic mutations of the MEN 1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57 . 4682-4686.
32. Debelenko L.V., et al. 1997. Identification of MEN 1 gene mutations in sporadic carcinoid of the lung. Hum Mol Genet 6 : 2285-2290.
33. Heppner C., et al. 1997. Somatic mutation of the MEN 1 gene in parathyroid tumors. Nat Genet 16 : 375-378.
34. Zhuang Z.P., et al. 1997. Mutations of the MEN 1 tumor suppressor gene in pituitary tumors. Cancer Res 57 : 5446-5451.
35. Teh B.T., McArdle J., Parameswaran V., David R., Larsson C., Sheperd J.J. 1996. Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1. Arch Surg 131 : 1230-1232.
36. Wassif W.S., Peters T.J. 1995. Familial isolated hyperparathyroidism. Clin Endocrinol 42 : 441-443.
37. Wassif W.S., et al. 1993. Familial isolated hyperparathyroidism : a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77 : 1485-1439.
38. Szabo J., et al. 1995. Hereditary hyperparathyroidism-jaw tumor syndrome : the endocrine tumor gene HRPT-2 maps to chromosome 1q21-31. Am J Hum Genet 56 : 944-950.
39. Teh B.T., et al. 1996. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease : linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81 : 4204-4211.
40. Inoue H., et al. 1995. Familial hyperparathyroidism associated with jaw fibroma : case report and literature review. Clin Endocrinol 43 : 225-229.
41. Benlian P., et al. 1995. Familial acromegaly : a specific clinical entity : further evidence from the genetic study of a three generation family. Eur J Endoc 133 : 451-456.
42. Berezin M., Karasik A. 1995. Familial prolactinoma. Clin Endocrinol 42 : 483-486.
43. Gordon R.D., Stowasser M., Klemm S.A., Tunny T.J. 1995. Primary hyperaldosteronism : some genetic, morphological and biochemical aspects of subtypes Steroids 60 : 35-41.
44. Calender A., et al. 1997. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia. Horm Res 47 : 199-210.
45. Mount S.L., Weaver D.L., Taatjes D.J., McKinnon W.C., Hebert J.C. 1995. Von Hippel-Lindau disease presenting as pancreatic neuroendocrine tumour. Virchows Arch 426 : 523-528.
46. Van Basten J.P., Van Hoek B., De Bruine A., Arends J.W., Stockbrugger R.W. 1994. Ampullary carcinoid and neurofibromatosis : case report and review of the literature. Neth J Med 44 : 202-206.
47. Teh B.T., et al. 1997. Clinicopathological studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 76 : 21-29.
48. Murat A., et al. 1997. Tumeurs neuroendocrines thymiques et bronchiques au cours des néoplasies endocriniennes multiples de type 1. Presse Med 26 : 1616-1621.
49. Petty E.M., Green J.S., Marx S.J., Taggart R.T., Farid N., Bale A.E. 1994. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN 1 BURIN) to chromosome 11 q : evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 54 : 1060-1066.
50. Friedman E., et al. 1989. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321 : 213-218.
51. Lubensky I.A., et al. 1996. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN 1 patients. Cancer Res 56 : 5272-5278.
52. Tomassetti P., et al. 1995. Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79 : 123-126.
53. Zimering M.B., et al. 1990. Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 70 : 149-154.
54. Zimering M.B., et al. 1997. Fibroblast growth factor-like autoantibodies in plasma from patients with multiple endocrine neoplasia type 1 (MEN 1) and prolactinoma. Ann NY Acad Sci 815 : 520-523.
55. Guru S.C., et al. 1998. Menin, the product of the MEN 1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95 : 1630-1634.